Overcoming barriers to deliver high-quality care requires an assessment of the contribution of each barrier within a local context. Tools to identify early disease, knowledge of best therapies, access to care providers and medications, and an accountable and integrated health-care system are essential elements of quality care. Education of patients, providers and policy makers in conjunction with advocacy efforts and national policy frameworks are required to deliver high-quality care worldwide.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century (US National Academies Press; 2001).
International Society of Nephrology. Global Kidney Health Atlas https://www.theisn.org/initiatives/global-kidney-health-atlas/ (2023).
Larmour, K. & Levin, A. Slowing progression in CKD: DAPA CKD and beyond. Clin. J. Am. Soc. Nephrol. 16, 1117–1119 (2021).
Noor, S. M. et al. IgA nephropathy: a review of existing and emerging therapies. Front. Nephrol. 3, 1175088 (2023).
Ronco, P., Plaisier, E. & Debiec, H. Advances in membranous nephropathy. J. Clin. Med. 10, 607 (2021).
Himmelfarb, J., Vanholder, R., Mehrotra, R. & Tonelli, M. The current and future landscape of dialysis. Nat. Rev. Nephrol. 16, 573–585 (2020).
Hernández, D. & Caballero, A. Kidney transplant in the next decade: strategies, challenges and vision of the future. Nefrología (Engl. Ed.) 43, 281–292 (2023).
Tuttle, K. R. et al. Clinical characteristics of and risk factors for chronic kidney disease among adults and children: an analysis of the CURE-CKD registry. JAMA Netw. Open 2, e1918169 (2019).
Wagner, E. H. et al. Improving chronic illness care: translating evidence into action. Health Aff. (Millwood) 20, 64–78 (2001).
Vanholder, R. et al. Inequities in kidney health and kidney care. Nat. Rev. Nephrol. 19, 694–708 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.L. has contributed to studies and participated in scientific advisory boards and data safety monitoring boards for Bayer, Astra Zeneca, Boehringer Ingelheim, Chinook, Janssen and Otsuka, and is active in numerous research and advocacy groups within the International Society of Nephrology.
Rights and permissions
About this article
Cite this article
Levin, A. Overcoming barriers to deliver high quality kidney care. Nat Rev Nephrol 20, 149–150 (2024). https://doi.org/10.1038/s41581-024-00807-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41581-024-00807-3
